Discontinuation report HYCAMTIN
| Report ID | 8129 |
| Drug Identification Number | 02231116 |
| Brand name | HYCAMTIN |
| Common or Proper name | Hycamtin4mg/Vials 5's |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TOPOTECAN |
| Strength(s) | 4MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 4mg x 5 |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-05-31 |
| Actual discontinuation date | 2019-06-10 |
| Remaining supply date | 2019-05-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Inventory on hand - expiration date 30.11.2019. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2019-06-11 | English | Compare |
| v17 | 2019-06-10 | French | Compare |
| v16 | 2019-06-10 | English | Compare |
| v15 | 2019-06-10 | English | Compare |
| v14 | 2019-03-08 | French | Compare |
| v13 | 2019-03-08 | English | Compare |
| v12 | 2019-02-11 | French | Compare |
| v11 | 2019-02-11 | English | Compare |
| v10 | 2019-02-11 | English | Compare |
| v9 | 2017-09-26 | French | Compare |
| v8 | 2017-09-26 | English | Compare |
| v7 | 2017-06-15 | French | Compare |
| v6 | 2017-06-15 | English | Compare |
| v5 | 2017-04-28 | French | Compare |
| v4 | 2017-04-28 | English | Compare |
| v3 | 2017-04-26 | French | Compare |
| v2 | 2017-04-26 | French | Compare |
| v1 | 2017-04-26 | English | Compare |
Showing 1 to 18 of 18